Pasar al contenido principal

SEÑALIZACION AXON-GLIAL EN LA BIOLOGIA Y FISIOPATOLOGIA DE LAS CELULAS DE SCHWANN

BFU2016-75864-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA EN LA COMUNITAT VALENCIANA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel EGR2 variant that associates with Charcot-Marie-Tooth disease when combined with lipopolysaccharide-induced TNF-α factor T49M polymorphism

  • Blanco-Cantó, Maria Empar
  • Patel, Nikiben
  • Velasco-Aviles, Sergio
  • Casillas-Bajo, Angeles
  • Salas-Felipe, Juan
  • García-Escrivá, Alexandre
  • Díaz-Marín, Carmen
  • Cabedo, Hugo
[Objective]: To identify novel genetic mechanisms causing Charcot-Marie-Tooth (CMT) disease., [Methods]: We performed a next-generation sequencing study of 34 genes associated with CMT in a patient with peripheral neuropathy., [Results]: We found a non–previously described mutation in EGR2 (p.P397H). P397H mutation is located within the loop that connects zinc fingers 2 and 3, a pivotal domain for the activity of this transcription factor. Using promoter activity luciferase assays, we found that this mutation promotes decreased transcriptional activity of EGR2. In this patient, we also found a previously described nonpathogenic polymorphism in lipopolysaccharide-induced TNF-α factor (LITAF) (p.T49M). We show that the p.T49M mutation decreases the steady-state levels of the LITAF protein in Schwann cells. Loss of function of LITAF has been shown to produce deregulation in the NRG1-erbB signaling, a pivotal pathway for EGR2 expression by Schwann cells. Surprisingly, our segregation study demonstrates that p.P397H mutation in EGR2 is not sufficient to produce CMT disease. Most notably, only those patients expressing simultaneously the LITAF T49M polymorphism develop peripheral neuropathy., [Conclusions]: Our data support that the LITAF loss-of-function interferes with the expression of the transcriptional-deficient EGR2 P397H mutant hampering Schwann cell differentiation and suggest that in vivo both genes act in tandem to allow the proper development of myelin., This work has been funded by grants BFU2016-75864R (MINECO Spanish Ministry for Economy and Competitiveness), PROMETEO 2018/114 (Conselleria Educació Generalitat Valenciana), and UGP-15-211 (FISABIO) to H. Cabedo., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Failures of nerve regeneration caused by aging or chronic denervation are rescued by restoring Schwann cell c-Jun

  • Wagstaff, Laura J.
  • Gómez-Sánchez, José A.
  • Fazal, Shaline V.
  • Otto, Georg W.
  • Kilpatrick, Alastair M.
  • Michael, Kirolos
  • Wong, Liam Y. N.
  • Ma, Ki H.
  • Turmaine, Mark
  • Svaren, John
  • Gordon, Tessa
  • Arthur-Farraj, Peter
  • Velasco-Aviles, Sergio
  • Cabedo, Hugo
  • Benito, Cristina
  • Mirsky, Rhona
  • Jessen, Kristjan R.
After nerve injury, myelin and Remak Schwann cells reprogram to repair cells specialized for regeneration. Normally providing strong regenerative support, these cells fail in aging animals, and during chronic denervation that results from slow axon growth. This impairs axonal regeneration and causes significant clinical problems. In mice, we find that repair cells express reduced c-Jun protein as regenerative support provided by these cells declines during aging and chronic denervation. In both cases, genetically restoring Schwann cell c-Jun levels restores regeneration to control levels. We identify potential gene candidates mediating this effect and implicate Shh in the control of Schwann cell c-Jun levels. This establishes that a common mechanism, reduced c-Jun in Schwann cells, regulates success and failure of nerve repair both during aging and chronic denervation. This provides a molecular framework for addressing important clinical problems, suggesting molecular pathways that can be targeted to promote repair in the PNS., HEALTH F2 2008-201535. Wellcome Trust. Medical Research Council. BFU2016-75864R. PID2019-109762RB-I00. Generalitat Valenciana. National Institute of Child Health and Human Development. National Institute of Neurological Disorders and Stroke (US)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A genetic compensatory mechanism regulated by Jun and Mef2d modulates the expression of distinct class IIa Hdacs to ensure peripheral nerve myelination and repair

  • Velasco-Aviles, Sergio
  • Patel, Nikiben
  • Casillas-Bajo, Angeles
  • Frutos-Rincón, Laura
  • Velasco, Enrique
  • Gallar, Juana
  • Arthur-Farraj, Peter
  • Gómez-Sánchez, José A.
  • Cabedo, Hugo
The class IIa histone deacetylases (HDACs) have pivotal roles in the development of different tissues. Of this family, Schwann cells express Hdac4, 5, and 7 but not Hdac9. Here, we show that a transcription factor regulated genetic compensatory mechanism within this family of proteins, blocks negative regulators of myelination ensuring peripheral nerve developmental myelination and remyelination after injury. Thus, when Hdac4 and 5 are knocked-out from Schwann cells in mice, a JUN-dependent mechanism induces the compensatory overexpression of Hdac7 permitting, although with a delay, the formation of the myelin sheath. When Hdac4, 5, and 7 are simultaneously removed, the myocyte-specific enhancer-factor d (MEF2D) binds to the promoter and induces the de novo expression of Hdac9, and although several melanocytic lineage genes are misexpressed and Remak bundle structure is disrupted, myelination proceeds after a long delay. Thus, our data unveil a finely tuned compensatory mechanism within the class IIa Hdac family, coordinated by distinct transcription factors, that guarantees the ability of Schwann cells to myelinate during development and remyelinate after nerve injury., This work has been funded by grants from the Ministerio de Economía y Competitividad (BFU2016-75864R and PID2019-109762RB-I00), ISABIAL (UGP18-257 and UGP-2019–128) to H Cabedo, and Conselleria Educació Generalitat Valenciana (PROMETEO 2018/114) to J Gallar and H Cabedo. Predoctoral fellowships ACIF/2 017/169 from Generalitat Valenciana (to L Frutos-Rincón) and FPU16/00283from Ministerio de Universidades are also acknowledged. The Instituto de Neurociencias is a 'Center of Excellence Severo Ochoa' (Ministerio de Economía y Competitividad SEV-2013-0317)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Emerging role of HDACs in regeneration and ageing in the peripheral nervous system: Repair Schwann cells as pivotal targets

  • Gómez-Sánchez, José A.
  • Patel, Nikiben
  • Martirena, Fernanda
  • Fazal, Shaline V.
  • Mutschler, Clara
  • Cabedo, Hugo
This article belongs to the Special Issue Neuroepigenetic: From Bench to Bedside., The peripheral nervous system (PNS) has a remarkable regenerative capacity in comparison to the central nervous system (CNS), a phenomenon that is impaired during ageing. The ability of PNS axons to regenerate after injury is due to Schwann cells (SC) being reprogrammed into a repair phenotype called Repair Schwann cells. These repair SCs are crucial for supporting axonal growth after injury, myelin degradation in a process known as myelinophagy, neurotropic factor secretion, and axonal growth guidance through the formation of Büngner bands. After regeneration, repair SCs can remyelinate newly regenerated axons and support nonmyelinated axons. Increasing evidence points to an epigenetic component in the regulation of repair SC gene expression changes, which is necessary for SC reprogramming and regeneration. One of these epigenetic regulations is histone acetylation by histone acetyl transferases (HATs) or histone deacetylation by histone deacetylases (HDACs). In this review, we have focused particularly on three HDAC classes (I, II, and IV) that are Zn2+-dependent deacetylases. These HDACs are important in repair SC biology and remyelination after PNS injury. Another key aspect explored in this review is HDAC genetic compensation in SCs and novel HDAC inhibitors that are being studied to improve nerve regeneration., This work has been funded by grants from the Ministerio de Economía y Competitividad (BFU2016-75864R and PID2019-109762RB-I00), ISABIAL (UGP18-257 and UGP-2019-128) to H. Cabedo and Conselleria Educació Generalitat Valenciana (PROMETEO 2018/114) to H. Cabedo. Medical Research Council (UK) studentship (2251399) to C. Mutschler., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Class IIa histone deacetylases link cAMP signaling to the myelin transcriptional program of Schwann cells

  • Gomis-Coloma, Clara
  • Velasco-Aviles, Sergio
  • Gómez-Sánchez, José A.
  • Casillas-Bajo, Angeles
  • Backs, Johannes
  • Cabedo, Hugo
Schwann cells respond to cyclic adenosine monophosphate (cAMP) halting proliferation and expressing myelin proteins. Here we show that cAMP signaling induces the nuclear shuttling of the class IIa histone deacetylase (HDAC)–4 in these cells, where it binds to the promoter and blocks the expression of c-Jun, a negative regulator of myelination. To do it, HDAC4 does not interfere with the transcriptional activity of MEF2. Instead, by interacting with NCoR1, it recruits HDAC3 and deacetylates histone 3 in the promoter of c-Jun, blocking gene expression. Importantly, this is enough to up-regulate Krox20 and start Schwann cell differentiation program–inducing myelin gene expression. Using conditional knockout mice, we also show that HDAC4 together with HDAC5 redundantly contribute to activate the myelin transcriptional program and the development of myelin sheath in vivo. We propose a model in which cAMP signaling shuttles class IIa HDACs into the nucleus of Schwann cells to regulate the initial steps of myelination in the peripheral nervous system., J. Backs was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 1118), the European Commission (FP7-Health-2010 and MEDIA-261409), the Deutsches Zentrum für Herz-Kreislauf-Forschung, and the German Ministry of Education and Research. This work has been funded by grants from the Ministerio de Economía y Competitividad (SAF2008-04106, PI012/164, and BFU2016-75864R), Conselleria Educació Generalitat Valenciana (PROMETEO 2008/134), and Fundación para el Fomento de la Investigación Saniatria y Biomédica de la Comunidad Valenciana (UGP-15-211) to H. Cabedo. The Instituto de Neurociencias is a ‘‘Center of Excellence Severo Ochoa” (Ministerio de Economía y Competitividad SEV-2013-0317)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARM1 detection in myelinating glia: sarm1/Sarm1 is dispensable for PNS and CNS myelination in zebrafish and mice

  • Fazal, Shaline V.
  • Mutschler, Clara
  • Chen, Civia Z.
  • Turmaine, Mark
  • Chen, Chiung-Ya
  • Hsueh, Yi-Ping
  • Ibañez-Grau, Andrea
  • Loreto, Andrea
  • Casillas-Bajo, Angeles
  • Cabedo, Hugo
  • Franklin, Robin J. M.
  • Barker, Roger A.
  • Monk, Kelly R.
  • Steventon, Benjamin J.
  • Coleman, Michael P.
  • Gómez-Sánchez, José A.
  • Arthur-Farraj, Peter
Since SARM1 mutations have been identified in human neurological disease, SARM1 inhibition has become an attractive therapeutic strategy to preserve axons in a variety of disorders of the peripheral (PNS) and central nervous system (CNS). While SARM1 has been extensively studied in neurons, it remains unknown whether SARM1 is present and functional in myelinating glia? This is an important question to address. Firstly, to identify whether SARM1 dysfunction in other cell types in the nervous system may contribute to neuropathology in SARM1 dependent diseases? Secondly, to ascertain whether therapies altering SARM1 function may have unintended deleterious impacts on PNS or CNS myelination? Surprisingly, we find that oligodendrocytes express sarm1 mRNA in the zebrafish spinal cord and that SARM1 protein is readily detectable in rodent oligodendrocytes in vitro and in vivo. Furthermore, activation of endogenous SARM1 in cultured oligodendrocytes induces rapid cell death. In contrast, in peripheral glia, SARM1 protein is not detectable in Schwann cells and satellite glia in vivo and sarm1/Sarm1 mRNA is detected at very low levels in Schwann cells, in vivo, in zebrafish and mouse. Application of specific SARM1 activators to cultured mouse Schwann cells does not induce cell death and nicotinamide adenine dinucleotide (NAD) levels remain unaltered suggesting Schwann cells likely contain no functionally relevant levels of SARM1. Finally, we address the question of whether SARM1 is required for myelination or myelin maintenance. In the zebrafish and mouse PNS and CNS, we show that SARM1 is not required for initiation of myelination and myelin sheath maintenance is unaffected in the adult mouse nervous system. Thus, strategies to inhibit SARM1 function to treat neurological disease are unlikely to perturb myelination in humans., CM was funded by a Medical Research Council (UK) studentship (2251399). PA-F (206634/Z/17/Z), AL (210904/Z/18/Z), CC (220027/Z/19/Z), RB (203151/Z/16/Z) and MC (220906/Z/20/Z) were funded by the Wellcome Trust (UK). BS was supported by a Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (109408/Z/15/Z). KM was funded by the National Institute of Neurological Disorders and Stroke Awards (R01NS079445). JG-S was funded by a Miguel Servet Fellowship (CP22/00078) from the Instituto de Salud Carlos III and the Millennium Nucleus for the Study of Pain (MiNuSPain), Santiago, Chile. HC was funded by the Spanish “Ministerio de Economía y Competitividad” (BFU2016-75864R and PID2019-109762RB-I00), ISABIAL (UGP18-257 and UGP-2019-128), and Generalitat Valenciana (PROMETEO 2018/114). Y-PH and C-YC were funded by Academia Sinica, AS-IA-106-L04 to Y-PH., Peer reviewed